University of Otago Cancer Genetics Laboratory principal investigator Prof Parry Guilford hopes to start a chemopreventative drug trial that could stop people who carry the CDH1 genetic mutation, from developing Hereditary Diffuse Gastric Cancer (HDGC). Photo: Gerard O'Brien